Department of Renal Medicine and Transplantation, The Royal London and St Bartholomew’s Hospitals, London, UK.
Nephrol Dial Transplant. 2011 May;26(5):1702-8. doi: 10.1093/ndt/gfq607. Epub 2010 Oct 4.
There is a wide disparity in the use of automated peritoneal dialysis (APD) or continuous ambulatory peritoneal dialysis (CAPD) in the UK. This may be due to a perceived quality of life and technique survival advantage with APD, although evidence is lacking.
We conducted a single-centre retrospective study of incident end-stage renal disease initiating APD and CAPD with data collected prospectively over 5 years. PD modality was based on patient preference. Health status was assessed using SF-36 questionnaires at initial and 1-year follow-up appointments.
Three hundred and seventy-two patients were included: 194 patients chose APD, and 178 patients chose CAPD. CAPD patients were generally older and more dependent than APD patients. Univariate analysis for technique survival was inferior for CAPD (relative risk for failure 1.46, 95% CI 1.08-1.97). But on multivariate analysis when comorbidity was added into the model, PD modality was no longer a significant predictor of technique survival. There was no difference in decline in residual renal function. Baseline CAPD patients had worse health status (HS); mean (SEM) physical and social composite scores were 32.3 (0.9) vs 36.5 (0.9) and 33.3 (1.2) vs 40.3 (1.2). After 1 year, HS scores for CAPD and APD patients were similar, but the improvement in HS scores correlated with baseline scores (PD modality was not an independent predictor of the change in HS).
This study did not show any advantages of APD over CAPD in terms of technique survival or HS. There is no evidence to support physician bias towards one PD modality, and both should be available to allow patient choice.
在英国,自动化腹膜透析(APD)或持续不卧床腹膜透析(CAPD)的使用存在很大差异。这可能是由于 APD 具有更高的生活质量和技术生存率优势,但目前缺乏证据。
我们进行了一项单中心回顾性研究,纳入了 5 年内开始接受 APD 和 CAPD 的终末期肾病患者。PD 模式基于患者的偏好。在初始和 1 年随访时使用 SF-36 问卷评估健康状况。
共纳入 372 名患者:194 名患者选择 APD,178 名患者选择 CAPD。CAPD 患者通常比 APD 患者年龄更大且依赖性更强。单因素分析显示 CAPD 的技术生存率较低(失败的相对风险为 1.46,95%CI 为 1.08-1.97)。但在多因素分析中,当将合并症纳入模型时,PD 模式不再是技术生存率的显著预测因素。残余肾功能下降无差异。基线时 CAPD 患者的健康状况(HS)较差;物理和社会综合评分的平均值(SEM)分别为 32.3(0.9)与 36.5(0.9)和 33.3(1.2)与 40.3(1.2)。1 年后,CAPD 和 APD 患者的 HS 评分相似,但 HS 评分的改善与基线评分相关(PD 模式不是 HS 变化的独立预测因素)。
本研究未显示 APD 在技术生存率或 HS 方面优于 CAPD。没有证据支持医生对一种 PD 模式的偏见,应该提供两种 PD 模式以允许患者选择。